Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2020
DOI: 10.1007/s13205-020-2151-4
|View full text |Cite
|
Sign up to set email alerts
|

Design of bioactive peptides derived from CART sequence isolated from the toadfish Thalassophryne nattereri

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 66 publications
0
2
0
Order By: Relevance
“…Using known sequencing information for specific peptides and manipulation on the molecular level resulted in the creation of novel peptides with improved anti-microbial properties (Conceição et al 2020 ). The designing of novel bioactive peptides was based on the computational algorithm and produced different analogs that were then tested for physiochemical stability and screened for anti-microbial properties.…”
Section: Mnp/maa Biotechnological Applicationsmentioning
confidence: 99%
“…Using known sequencing information for specific peptides and manipulation on the molecular level resulted in the creation of novel peptides with improved anti-microbial properties (Conceição et al 2020 ). The designing of novel bioactive peptides was based on the computational algorithm and produced different analogs that were then tested for physiochemical stability and screened for anti-microbial properties.…”
Section: Mnp/maa Biotechnological Applicationsmentioning
confidence: 99%
“…E. coli, for example, is mostly harmless, but under abnormal growth it can cause serious diseases in humans, such as gastroenteritis and infections in the urinary tract, bloodstream and central nervous system. In an attempt to minimize the problem of drug resistance, some alternatives have been considered, such as the development of new antibiotics [22] or the development of alternative therapies such as the therapy based on the use of bioactive peptides [23][24][25]; phytochemicals or nanoparticles [26][27][28]. Antimicrobial photodynamic therapy (aPDT) is another example of alternative therapy that has shown encouraging results in experimental and clinical applications.…”
Section: Introductionmentioning
confidence: 99%
“…);Conceição et al (2020);Corrêa et al (2011);Cruz et al (2020);Dornelles et al (2018);Fagundes et al (2011);Ferreira et al (2015);Fontenele et al (2017);Galli et al (2019);Games et al (2016); Lima et al (2018); Luz et al (2017); Machado et al (2012); Machado et al (2016); Mandal et al (2014); Meira et al (2012); Migliolo et al (2016); Nascimento et al (2021b); Oliveira et al (2019c); Sanches et al (2021); Santana et al (2020); Santos et al (2021); Silva et al (2019a); Torres-Rêgo et al (2019); Zanutto-Elgui et al (2019); Plácido et al (2020); Oliveira Filho et al (2021) Anticancer Inhibition of cancer cell proliferation Arruda et al (2017); Assis et al (2016); Brand et al (2019); Crusca Jr. et al (2018); Daroit et al (2012); Dematei et al (2021); Figueiredo et al (2015); Fontenele et al (2017); Galli et al (2019); Gomes et al (2020); Lima et al (2015); Lima et al (2020); Magalhães et al (2013); Martins et al (2019); Massaoka et al (2014); Matsuo et al (2011); Mello et al (2015); Mello et al (2020); Montalvo et al (2019); Nascimento et al (2011); Quadros et al (2019); Ramada et al (2017); Silva et al (2012); Silva-Stenico et al (2011); Torres et al (2018); Yekta et al glucose levels (hyperglycemia and hypoglycemia) Baptista et al (2020b); Barati et al (2020); Brandelli et al (2015); Callegaro et al (2018); Henaux et al (2021); Landim et al (2021); Martins-Santos et al (2011); Ohara et al (2020); Rocha et al (2015); Vogel et al (2021) Antigenicity Interaction with previously sensitized T and B lymphocytes Landim et al (2021) Continue...…”
mentioning
confidence: 99%